Expression and Prognostic Value of IFIT1 and IFITM3 in Head and Neck Squamous Cell Carcinoma

Identification of Potential Candidate Genes of Oral Cancer in Response to Chronic Infection With Porphyromonas gingivalis Using Bioinformatical Analyses

(2019) Fengxue Geng et al.   Frontiers in Oncology

Overexpression of Golgi Phosphoprotein 2 Is Associated With Poor Prognosis in Oral Squamous Cell Carcinoma

(2018) Hao Li et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Cancer statistics, 2018

(2018) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancer immunoediting and resistance to T cell-based immunotherapy

(2018) Jake S. O’Donnell et al.   Nature Reviews Clinical Oncology

The immune contexture in cancer prognosis and treatment

(2017) Wolf H. Fridman et al.   Nature Reviews Clinical Oncology

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

(2017) Zefang Tang et al.   NUCLEIC ACIDS RESEARCH

Genetic etiology of oral cancer

(2017) Johar Ali et al.   ORAL ONCOLOGY

IFI16 is required for DNA sensing in human macrophages by promoting production and function of cGAMP

(2017) K. L. Jønsson et al.   Nature Communications

PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma

(2017) Tim Müller et al.   Oncotarget

Overexpression of IFITM3 predicts poor prognosis in stage IIA esophageal squamous cell carcinoma after Ivor Lewis esophagectomy

(2017) Yang Jia et al.   Thoracic Cancer

B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma

(2016) Lei Wu et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma

(2016) Nghia Nguyen et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family

(2016) Frank A. Schildberg et al.   IMMUNITY

Prognostic gene expression profiling in esophageal cancer: a systematic review

(2016) Els Visser et al.   Oncotarget

Macrophages and Therapeutic Resistance in Cancer

(2015) Brian Ruffell et al.   CANCER CELL

Metabolic Reprogramming of Immune Cells in Cancer Progression

(2015) Subhra K. Biswas   IMMUNITY

Immunology and Immunotherapy of Head and Neck Cancer

(2015) Robert L. Ferris   JOURNAL OF CLINICAL ONCOLOGY

PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma

(2015) Guang-Tao Yu et al.   Oncotarget

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Mechanism and biological significance of the overexpression of IFITM3 in gastric cancer

(2014) JUN HU et al.   ONCOLOGY REPORTS

The role of IFITM3 in the growth and migration of human glioma cells

(2013) Bing Zhao et al.   BMC Neurology

Interferon-Induced Protein with Tetratricopeptide Repeats 1 (IFIT1) as a Prognostic Marker for Local Control in T1-2 N0 Breast Cancer Treated with Breast-Conserving Surgery and Radiation Therapy (BCS + RT)

(2013) Hasan H. Danish et al.   Breast Journal

Phase II trial of sequential subcutaneous interleukin-2 plus interferon alpha followed by sorafenib in renal cell carcinoma (RCC)

(2013) J. P. Maroto et al.   Clinical & Translational Oncology

Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle

(2013) MEI YANG et al.   ONCOLOGY REPORTS

Overexpression of the DNA sensor proteins, absent in melanoma 2 and interferon-inducible 16, contributes to tumorigenesis of oral squamous cell carcinoma with p53 inactivation

(2012) Yuudai Kondo et al.   CANCER SCIENCE

Prognostic value of clinicopathological parameters and outcome in 484 patients with oral squamous cell carcinoma: microvascular invasion (V+) is an independent prognostic factor for OSCC

(2012) M. Grimm   Clinical & Translational Oncology

Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization

(2012) Jan Budczies et al.   PLoS One

KLF4-Mediated Negative Regulation of IFITM3 Expression Plays a Critical Role in Colon Cancer Pathogenesis

(2011) D. Li et al.   CLINICAL CANCER RESEARCH

IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA

(2011) Andreas Pichlmair et al.   NATURE IMMUNOLOGY

G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer

(2011) V Cheriyath et al.   ONCOGENE

Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas

(2011) Klaus Laimer et al.   ORAL ONCOLOGY

An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer

(2008) R. R. Weichselbaum et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA